In a nutshell: Haematological immune‐related adverse events
British Journal of Haematology · 2026-11 · 209 (5) · 2007-2010
DOI: 10.1111/bjh.70782 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 24.08.2026. Verfasst von Rebecca K Leaf und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Hematology, Mass General Brigham Cancer Institute, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Hematologic Diseases. Die Arbeit nennt 15 Literaturangaben. Gefördert von: NIH HHS, National Institutes of Health.
Themen: Patientensicherheit
Abstract (Originalsprache)
The use of immune checkpoint inhibitors (ICIs) have transformed oncological care. In this ‘nutshell review’, we summarize the most common haematological immune‐related adverse events (irAEs) associated with checkpoint inhibitors. We also outline management strategies and address current evidence regarding ICI rechallenge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Hematology, Mass General Brigham Cancer Institute, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Hematology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Rebecca K Leaf, Jodi V Mones
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Leaf, R. K., & Mones, J. V. (2026). In a nutshell: Haematological immune‐related adverse events. British Journal of Haematology, 209(5), 2007-2010. https://doi.org/10.1111/bjh.70782
Vancouver
Leaf RK, Mones JV. In a nutshell: Haematological immune‐related adverse events. British Journal of Haematology. 2026;209(5):2007-2010. doi:10.1111/bjh.70782
BibTeX
@article{Leaf2026,
author = {Leaf, Rebecca K and Mones, Jodi V},
title = {In a nutshell: Haematological immune‐related adverse events},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {5},
pages = {2007--2010},
doi = {10.1111/bjh.70782}
}
EUVIMED